3 completed. 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Bateman Horne Center: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2 Valacyclovir celecoxib dose 1, Valacyclovir celecoxib dose 2, Placebo - Long COVID, PASC Post Acute Sequelae of COVID 19 | Phase 2 | Completed | Bateman Horne Center | 59 | 2023-10-15 | 2025-01-22 |
| REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID Anhydrous Enol-Oxaloacetate, a "Medical Food", White Rice Flour - Post-COVID-19 Syndrome, Fatigue Syndrome, Chronic | Not applicable | Completed | Terra Biological LLC | 70 | 2023-06-01 | 2025-02-04 |
| RESTORE ME -- RCT of Oxaloacetate on Improving Fatigue in ME/CFS Placebo, Medical Food - Anhydrous Enol-Oxaloacetate - Myalgic Encephalomyelitis, Chronic Fatigue Syndrome | Not applicable | Completed | Terra Biological LLC | 82 | 2022-03-15 | 2025-02-04 |
Fatigue (2) · Fatigue Syndrome, Chronic (2) · Post-Acute COVID-19 Syndrome (2)
Oxaloacetic Acid (2) · DMAC2L protein, human (1) · Flour (1)
United States (3)
Lucinda Bateman, MD (2) · Suzanne D Vernon, Ph.D. (1)